Today, #Kognitic opens public access to our insight-driven, live dashboard to keep abreast of all the #Covid19 clinical developments! Updated daily with data sourced directly from […]

Behind-the-Scenes Heroes of COVID-19 #Kognitic would like to take a moment to thank the #researchers who are working unremittingly to find a #cure for #covid19. These […]

Kognitic announces the launch of an innovative feature to its platform, one which allows its customers to plot the geographic location of active clinical trials into […]

Cancer Care in the Time of Covid-19 While it seems much of our world has come to a halt since the spread of #covid19 , cancer […]

With over 1 million globally confirmed Covid-19 cases, the promise of bringing lives back to ‘normal’ seems ambiguous. Amidst several strategies to fight against the disease, […]

University of #Penn refuses to stop innovating. After having introduced CAR-T to the fight against #cancer, another Penn team has developed an a related technology which […]

Imalumab is the only drug targeting oxMIF to reach #clinicaltrials, but ultimately was terminated due to poor overall benefit-risk assessment. Now, OncoOne has announced that they […]

Merck KGaA’s MET inhibitor, Tepotinib, received approval in Japan for #NSCLC yesterday, gaining a lead in the tight race against Capmatinib – Novartis’ MET inhibitor. The […]

On International Day of Women in Science. #Kognitic would like to celebrate the great strides which women are making in science. At our company women account […]